Global NPHP5 Retinal Degeneration Treatment Market, By Treatment Type, By Indication, By Distribution Channel, By Geography
상품코드:1707354
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 NPHP5 망막 변성 치료 시장은 2025년에는 1,580만 달러에 달하고, 2032년에는 1억 3,330만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 35.6%를 나타낼 전망입니다.
보고 범위
보고서 세부정보
기준 연도
2024년
시장 규모(2025년)
1,580만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간 : 2025-2032년 CAGR :
35.60%
가치 예측(2032년)
1억 3,330만 달러
그림. 세계의 NPHP5 망막 변성 치료 시장 점유율(%), 지역별(2025년)
시니어-로켄 증후군 7로도 알려진 NPHP5 망막 변성은 진행성 시각 장애를 일으키고 완전 실명으로 이어질 수 있는 드문 유전성 섬모증입니다. 이 질병은 망막 색소 변성, 네플로제 및 기타 전신 병변을 특징으로 합니다. 최근 발병 기전에 대한 연구는 섬모 기능과 같은 잠재적 창약 표적을 발견하고 치료 개발의 새로운 길을 열고 있습니다. 임상시험을 개시하고 있습니다. 시니어 로켄(SL)은 상염색체 열성 증후군이며 낭포성 신질환이 망막이영양증(망막 색소변성 또는 레이버 선천성 흑내장)을 수반하는 네프로제 관련 질환의 변종입니다.
시장 역학 :
NPHP5 망막 변성 치료 시장은 이 쇠약성 질환에 대한 효과적인 치료에 대한 높은 암메트 메디컬 니즈에 의해 견인되고 있습니다. 시장 성장을 더욱 뒷받침하고 있습니다만, 눈에의 유전자 도입에 수반하는 기술적 과제나 희귀질환 치료제의 높은 개발 비용이 계속해서 시장 수익을 억제하고 있습니다.
본 조사의 주요 특징
본 보고서에서는 세계의 NPHP5 망막 변성 치료 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또한 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
이 보고서는 세계의 NPHP5 망막 변성 치료 시장 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등의 매개 변수를 기반으로 소개합니다. Therapeutics사, MeiraGTx사, NightstaRx사, Beacon Therapeutics사, Applied Genetic Technologies Corporation사, ViGeneron사, RetinAI Medical사 등이 있습니다.
이 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관해서, 정보에 근거한 의사 결정을 실시할 수 있습니다.
세계의 NPHP5 망막 변성 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계의 NPHP5 망막변성 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
계발 캠페인의 전개 증가
긴 승인 기간
아시아태평양 및 라틴아메리카의 신흥 시장
주요 하이라이트
규제 시나리오
시장 동향
PEST 분석
PORTER 분석
제품 발매
역학
합병, 인수 및 제휴
제4장 세계의 NPHP5 망막 변성 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향
제5장 세계의 NPHP5 망막 변성 치료 시장, 치료 유형별(2020-2032년)
유전자 치료
약물 치료
기타
제6장 세계의 NPHP5 망막 변성 치료 시장, 적응증별(2020-2032년)
망막 색소 침착증
레베르 선천성 무모증
어셔 증후군
기타
제7장 세계의 NPHP5 망막 변성 치료 시장, 유통 채널별(2020-2032년)
소매 약국
병원 약국
온라인 약국
제8장 세계의 NPHP5 망막 변성 치료 시장, 지역별(2020-2032년)
북미
유럽
아시아태평양
라틴아메리카
중동
아프리카
제9장 경쟁 구도
기업 프로파일
ProQR Therapeutics
Editas Medicine
Nanoscope Therapeutics, Inc.
jCyte, Inc.
Biogen
Novartis AG
Spark Therapeutics
MeiraGTx
NightstaRx
Beacon Therapeutics
Applied Genetic Technologies Corporation
ViGeneron
RetinAI Medical
제10장 섹션
참고문헌
조사 방법
출판사에 대해
KTH
영문 목차
영문목차
Global NPHP5 Retinal Degeneration Treatment Market is estimated to be valued at USD 15.8 Mn in 2025 and is expected to reach USD 133.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 35.6% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 15.8 Mn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
35.60%
2032 Value Projection:
USD 133.3 Mn
Figure. Global NPHP5 Retinal Degeneration Treatment Market Share (%), By Region 2025
NPHP5 retinal degeneration, also known as Senior-Loken syndrome 7, is a rare genetic ciliopathy that causes progressive visual impairment and can lead to complete blindness. It is caused by mutations in the NPHP5 gene, which encodes for nephrocystin-5, a protein critical for cilia function. The condition is characterized by retinitis pigmentosa, nephronophthisis, and other systemic involvement. Currently, there is no approved treatment for NPHP5 retinal degeneration, and management involves low vision aids and supportive care. However, recent research investigating the pathogenic mechanisms has uncovered potential drug targets such as cilia function, which is opening up new avenues for treatment development. Several biopharmaceutical companies have started clinical trials evaluating gene therapy and other novel therapeutic approaches to restore vision in these patients. Senior-Loken (S-L) is an autosomal recessive syndrome and a variant of the nephronophthisis-associated disorders, in which the cystic kidney disease is associated with retinal dystrophy (retinitis pigmentosa or Leber congenital amaurosis). It is a deleterious disease that culminates in blindness and renal failure.
Market Dynamics:
The NPHP5 retinal degeneration treatment market is driven by the high unmet medical need for an effective treatment for this debilitating condition. As per estimates, NPHP5 retinal degeneration has a prevalence of 1 in 200,000 live births globally. The increasing research focus on cilia pathways and recent breakthroughs in retinal gene therapy are further boosting market growth by expanding therapeutic opportunities. However, technical challenges associated with ocular gene delivery and the high costs of developing orphan disease therapies continue to restrain market revenues. On the other hand, partnerships between biotech firms and research institutions, growing public-private funding for rare disease, research and development present lucrative opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global NPHP5 retinal degeneration treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global NPHP5 retinal degeneration treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include ProQR Therapeutics, Editas Medicine, Nanoscope Therapeutics, Inc., jCyte, Inc., Biogen, Novartis AG, Spark Therapeutics, MeiraGTx, NightstaRx, Beacon Therapeutics, Applied Genetic Technologies Corporation, ViGeneron and RetinAI Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global NPHP5 retinal degeneration treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global NPHP5 retinal degeneration treatment market
Detailed Segmentation:
Global NPHP5 Retinal Degeneration Treatment Market, By Treatment Type
Gene Therapy
Cell Therapy
Drug Therapy
Others
Global NPHP5 Retinal Degeneration Treatment Market, By Indication
Retinitis Pigmentosa
Leber Congenital Amaurosis
Usher Syndrome
Others
Global NPHP5 Retinal Degeneration Treatment Market, By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global NPHP5 Retinal Degeneration Treatment Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles
ProQR Therapeutics
Editas Medicine
Nanoscope Therapeutics, Inc.
jCyte, Inc.
Biogen
Novartis AG
Spark Therapeutics
MeiraGTx
NightstaRx
Beacon Therapeutics
Applied Genetic Technologies Corporation
ViGeneron
RetinAI Medical
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Treatment Type
Market Snippet, By Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing Launch of Awareness Campaigns
Long approval timelines
Emerging markets in Asia Pacific and Latin America
Key Highlights
Regulatory Scenario
Market Trends
PEST Analysis
PORTER's Analysis
Product Launches
Epidemiology
Mergers, Acquisitions, and Collaborations
4. Global NPHP5 Retinal Degeneration Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global NPHP5 Retinal Degeneration Treatment Market, By Treatment Type, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Drug Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
6. Global NPHP5 Retinal Degeneration Treatment Market, By Indication, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Retinitis Pigmentosa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Leber Congenital Amaurosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Usher Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
7. Global NPHP5 Retinal Degeneration Treatment Market, By Distribution Channel, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
8. Global NPHP5 Retinal Degeneration Treatment Market, By Region, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021 -2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
